匯盈控股(00821.HK)擬成立合資公司進入銷售推廣虛擬產品業務
格隆匯12月28日丨匯盈控股(00821.HK)發佈公吿,2021年12月24日,公司全資附屬公司前海滙盈與深圳市倚雲信息電子有限公司(“深圳倚雲信息”)及李曉雯成立合資公司深圳市滙微多盈科技有限公司,分別持有合資公司51%、25%和24%的股權。
合資公司主要從事虛擬資產銷售及推廣業務,計劃包括但不限於騰訊公司虛擬產品銷售及推廣業務,並預期從騰訊虛擬產品經銷商處獲取獨家銷售權。騰訊公司虛擬產品覆蓋騰訊遊戲、QQ、視頻、音樂等領域。董事會相信透過合資公司進入銷售及推廣虛擬產品業務,可拓展集團在互聯網領域的競爭力及提升盈利能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.